Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-014727
Filing Date
2020-06-01
Accepted
2020-06-01 16:28:18
Documents
1
Period of Report
2020-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1539
  Complete submission text file 0000899243-20-014727.txt   3034
Mailing Address BAIN CAPITAL, LLC 200 CLARENDON STREET BOSTON MA 02116
Business Address
PATRICK DEVAL L (Reporting) CIK: 0001053466 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37539 | Film No.: 20933711
SIC: 4512 Air Transportation, Scheduled

Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

EIN.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations